top of page

Field Medical's FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.




Field Medical's FieldForce™ Ablation System, the first and only contact force pulsed field ablation (PFA) system, has received FDA TAP Pilot acceptance and Breakthrough Device Designation for its revolutionary approach to treating ventricular tachycardia (VT). This critical advancement is set to redefine care for patients at risk of sudden cardiac death from VT.


Read the full press release here.

166 views0 comments

Comentarios


Los comentarios se han desactivado.
bottom of page